Anavex Life Sciences Corp (AVXL)

[Talon38]

Cat....you are absolutely right. The MTA and the subsequent sustained period of negotiation has been discussed ad infinitum. Wayne State University's investigation of 2-73 and its possible remyelination capabilities pointed to future success in MS. The Alzheimer's conflict between 2-73 and Biogen's Aducanumab/BAN2401 was the cause of the negotiation breakdown and it was Anavex who most likely left the table first.

And on the question of who is a fool......it's certainly not Steady_T!